Sexually Transmitted Disease Surveillance 1996
Division of STD Prevention September 1997 U.S. Department of Health and Human Services Public Health Service Centers for Disease Control and Prevention National Center for HIV, STD, and TB Prevention Division of STD Prevention Atlanta, Georgia 30333 Copyright Information All material contained in this report is in the public domain and may be used and reprinted without special permission; citation to source, however, is appreciated. Suggested Citation Division of STD Prevention. Sexually Transmitted Disease Surveillance, 1996. U.S. Department of Health and Human Services, Public Health Service. Atlanta: Centers for Disease Control and Prevention, September 1997. Copies can be obtained from the Office of Communications, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E-06, Atlanta, Georgia 30333. The reports for 1993 through 1996 are available electronically on CDC WONDER. For information about registering for CDC WONDER, please contact CDC's Epidemiology Program Office at (888) 496-8347. These reports are also available from the Internet via the CDC home page address http://wonder.cdc.gov/wonder/data/Reports.html. Appendix Sources and Limitations of Data CDC Surveillance Data Much of the information in this document was based on cases of sexually transmitted diseases (STDs) reported to the Division of STD Prevention (DSTDP), Centers for Disease Control and Prevention (CDC), by the STD control programs and health departments in the 50 states, the District of Columbia, selected cities, U.S. dependencies and possessions, and independent nations in free association with the United States. Included among the dependencies, possessions, and independent nations are Guam, Puerto Rico, and the Virgin Islands. These entities are identified as "outlying areas of the U.S." in selected tables and figures. At present, STD data are submitted to CDC on a variety of hardcopy summary reports (monthly, quarterly, and annually) and electronically either in summary or individual case-listed format. DSTDP is currently working on converting from hardcopy reporting of summary data to electronic submission of line-listed (i.e., case-specific) data. The data used in this report are predominantly based on the summary hardcopy reports. Monthly reports included summary data for syphilis by county and state. Quarterly reports included summary data for syphilis, gonorrhea, chlamydia, and other STDs by gender and source of report (STD clinic or non-STD clinic) for the 50 states, 64 large cities (most with a population over 200,000 in 1980), and outlying areas of the United States. Annual reports included summary data for syphilis, gonorrhea, and chlamydia by age, race, and gender for the 50 states and six large cities. In addition, data on antimicrobial susceptibility in Neisseria gonorrhoeae were collected through the Gonococcal Isolate Surveillance Project (GISP), a sentinel system of 25 STD clinics and five laboratories located throughout the United States. Provisional data on syphilis, gonorrhea, and chlamydia reported to CDC weekly by states for inclusion in the Morbidity and Mortality Weekly Report were not included in this document. Areas differ in their ability to resolve differences in total cases derived from hardcopy monthly, quarterly, and annual reports (as well as electronically submitted case-listed data). Thus, depending on the database used, there may be discrepancies in total cases in the tables and figures. In most instances, these discrepancies are less than 5% of total reported cases and have minimal impact on national total cases and rates. However, for a specific area, the discrepancies may be larger. Reports and corrections sent to CDC through June 13, 1997 have been included. Those received after this date will appear in subsequent issues. The data in the tables and figures in this document supersede those in all earlier publications. Population Denominators and Rate Calculations Crude incidence rates (new cases/population) were calculated on an annual basis per 100,000 population. For the United States, rates were calculated using Bureau of the Census population estimates for 1981 through 1989 (Bureau of the Census; United States Population Estimates by Age, Sex and Race: 1980-1989 {Series P-25, No. 1045}; Washington: US Government Printing Office, 1990; and United States Population Estimates by Age, Sex and Race: 1989 {Series P-25, No. 1057}; Washington: US Government Printing Office, 1990). Rates for states and counties were calculated using published intercensal estimates based on Bureau of the Census population estimates for 1980-1989 (Irwin R; 1980-1989 Intercensal Population Estimates by Race, Sex, and Age; Alexandria, {VA}: Demo-Detail, 1992; machine-readable data file). Rates for 1990 were calculated using population data from the 1990 census (Census of Population and Housing, 1990: Summary Tape File 1 (All States) {machine-readable file}; Washington: Bureau of the Census, 1991), which included information on area (county, state), age (5-year age groups), race (White, Black, Asian/Pacific Islander, American Indian/Alaska Native) and ethnicity (Hispanic). Rates for 1991-1994 were updated from previous issues of this report using postcensal population estimates based on the Bureau of the Census data (U.S. Bureau of the Census; 1991-1994 Estimates of the Population of Counties by Age, Sex and Race/Hispanic Origin: 1990 to 1994; machine-readable data file). Rates for 1995 and 1996 use extrapolated population estimates for 1995. Many cities do not have a separate health jurisdiction that collects and reports cases of STDs. For these cities, case numbers and crude incidence rates are equal to those of the county or counties in which the city is located. For the remaining cities, incidence rates were calculated by using population estimates based on the Bureau of the Census (Irwin R, see above) and a marketing survey (Market Statistics, Inc; Sales and Marketing Management; New York: Bill Communications, Inc, August 1989). 1980-1988 population estimates for areas outside the United States were obtained from the Bureau of the Census (Bureau of the Census; population estimates for Puerto Rico and the outlying areas: 1980 to 1988; Current Population Reports {Series P-25, No. 1049}; Washington: US Government Printing Office, 1989). After 1988, population estimates for outlying areas were obtained directly from the health departments in these areas. For Puerto Rico, population estimates for 1996 were based on 1995 population estimates. For the Virgin Islands, rates for 1993-1996 were based on 1992 population estimates, and for Guam, rates for 1991-1996 were based on 1990 population estimates because more current estimates were unavailable. The percentage of cases for which race/ethnicity and age were unknown or unspecified differed considerably, depending on year and area. In 1983 and 1984, up to 25% of total U.S. cases were in this category. In these years, states were excluded from analysis if race/ethnicity and age were not reported for the majority of cases. Otherwise, if race/ethnicity or age was unknown or unspecified, cases were distributed according to the distribution of cases for which these data were available. In this edition, 1981 through 1996 age- and race-specific rates (for chlamydia (1996 only), gonorrhea, and syphilis in the National Profile, Special Focus Profiles and Detailed Tables) are calculated from estimates based on this redistribution. Rates of congenital syphilis for 1989-1996 were calculated using live births from the National Center for Health Statistics (NCHS) (Vital Statistics: Natality Tapes 1989-1994 or Vital Statistics Reports, United States 1997, Vol. 45 No.6--Natality). Race-specific rates for 1995-1996 were calculated using live births for 1994. Rates before 1989 were calculated using published live birth data (NCHS; Vital Statistics Report, United States, 1988 {Vol.1--Natality}). Case Definitions and Reporting Practices Although most areas generally adhere to the case definitions for STDs found in Case Definitions for Public Health Surveillance (MMWR 1990;39(RR-13): 1-43), there are significant differences between individual areas in case definitions as well as in the policies and systems for collecting surveillance data. Thus, comparisons of case numbers and rates between areas should be interpreted with caution. However, since case definitions and surveillance activities within a given area remain relatively stable, trends should be minimally affected. In many areas, reporting from publicly supported institutions (e.g., STD clinics) was more complete than from other sources (e.g., private practitioners). Thus, the trends may not be representative of all segments of the population. Military cases are not reported as a separate category. Reporting of Congenital Syphilis Cases In 1989, a new surveillance case definition for congenital syphilis was introduced. The new case definition has greater sensitivity than the former definition. In addition, many areas greatly enhanced active case finding for congenital syphilis during this time. For these reasons, the number of reported cases increased dramatically during 1989-1991. As is true of any change, a period of transition during which trends cannot be clearly interpreted has resulted; however, all reporting areas had implemented the new case definition for reporting all cases of congenital syphilis after January 1, 1992. Therefore, the reliability of trends is expected to have stabilized after this date. In addition to changing the case definition, CDC introduced a new data collection form (CDC 73.126) in 1990. Beginning with 1995, the data collected on this form are used for reporting congenital syphilis reported cases and associated rates. This form collects individual case information which allows more thorough analysis of cases. For the purposes of these analyses if either race or ethnicity question was answered, the case was included. For example, if "White" race was marked, but ethnicity was left blank, the individual was counted as "non-Hispanic White". Reporting of Gonorrhea Cases In 1994, Georgia reported gonorrhea cases to CDC for only part of a year. Therefore, Georgia cases and population were excluded from gonorrhea figures and tables for 1994. The city of Atlanta was also excluded from city figures and tables for 1994. Reporting of Chlamydia Cases Effective February 1996, Alaska initiated mandatory reporting of Chlamydia. In 1996, New York was the only state that did not yet have laws or policies for uniform reporting of Chlamydia trachomatis cases. Chlamydia cases for New York were exclusively based on cases reported by New York City (i.e., no cases were reported outside of New York City). When calculating U.S. total rates, the population denominators were adjusted to include only the New York City population. Trends in many areas were more representative of increases in reporting of cases rather than actual trends in disease. Cases and rates of chlamydia reported in gender-specific tables are underestimated due to some reported cases with unknown gender. Despite problems with under-reporting, it is important to publish the data to emphasize the large numbers of cases of chlamydia being detected in the United States. As areas develop chlamydia prevention and control programs, including improved surveillance systems to monitor trends, the data should improve and become more representative of true trends in disease. Chlamydia test positivity was calculated by dividing the number of women testing positive for chlamydia (numerator) by the total number of women tested for chlamydia (denominator) and was expressed as a percentage. While not common, the denominator may contain multiple tests from the same individual if that person was tested more than once during a year. Various chlamydia test methods were used and no adjustments of test positivity were made based on test type. Chlamydia testing data for region- and state-specific figures were published with permission from the HHS Regional Infertility Prevention Programs, selected state STD prevention programs, and the Job Corps, U.S. Department of Labor. Health and Human Services (HHS) regions are as follows: Region I=Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont; Region II=New Jersey, New York, Puerto Rico, and U.S. Virgin Islands; Region III=Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, and West Virginia; Region IV=Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee; Region V=Illinois, Indiana, Michigan, Minnesota, Ohio, and Wisconsin; Region VI=Arkansas, Louisiana, New Mexico, Oklahoma, and Texas; Region VII=Iowa, Kansas, Missouri, and Nebraska; Region VIII=Colorado, Montana, North Dakota, South Dakota, Utah, and Wyoming; Region IX=Arizona, California, Guam, Hawaii, and Nevada; and Region X=Alaska, Idaho, Oregon, and Washington. Other Data Sources The information on the number of initial visits to private practitioners' offices for sexually transmitted diseases was based on analysis of data from the National Disease and Therapeutic Index (NDTI) (machine-readable files or summary statistics for years 1966-1996). For more information on this database, contact IMS America, Ltd., 660 West Germantown Pike, Plymouth Meeting, PA 19462; Telephone: (610) 834-5000. The information on patients hospitalized for pelvic inflammatory disease or ectopic pregnancy was based on analysis of data from the National Hospital Discharge Survey (machine-readable files for years 1980-1994), an ongoing nationwide sample survey of short-stay hospitals in the United States, conducted by the National Center for Health Statistics. For more information, see Graves EJ; 1988 Summary: National Hospital Discharge Survey; Advance data No. 185; Hyattsville (MD): National Center for Health Statistics, 1990. The National Hospital Ambulatory Medical Care Survey (NHAMCS) (machine-readable file for 1994) was used to obtain estimates of the number of emergency room visits for pelvic inflammatory disease among women ages 15 to 44. The estimates generated using these data sources (NHDS and NHAMCS) are based on statistical surveys and therefore have sampling variability associated with the estimates. Healthy People Year 2000 Revisions In 1995, the Healthy People year 2000 objectives were revised (1). The year 2000 objectives for the diseases in this report were revised as follows: primary and secondary syphilis -- 10 per 100,000 population to 4; congenital syphilis -- 50 per 100,000 livebirths to 40; and gonorrhea -- 225 per 100,000 population to 100. ---------- (1) Department of Health and Human Services. Healthy People 2000: Midcourse Review and 1995 Revisions. U.S. Department of Health and Human Services, Public Health Service. U.S. Government Printing Office, Washington, D.C., 1995. Table_A1. Healthy People 2000 Sexually Transmitted Diseases Objective Status Table_STD STD Project Directors, STD Program Managers, and State and Territorial Epidemiologists
This page last reviewed: Monday, February 01, 2016
This information is provided as technical reference material. Please contact us at cwus@cdc.gov to request a simple text version of this document.